Clinical Trial Update: Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing vonoprazan (TAK-438) with lansoprazole for treating erosive esophagitis has completed, evaluating relative efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• PREVACID (LANSOPRAZOLE)
• Vonoprazan (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED